Prevail Therapeutics logo

Prevail Therapeutics

Prevail Therapeutics is developing disease-modifying gene therapies for patients with Parkinson’s disease and other neurodegenerative disorders.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.prevailtherapeutics.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
430 East 29th Street, Suite 940, NY 10016
New York
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/prevail-therapeutics” connections=”true” suffix=””]